Veradermics (MANE) Amortizatization of Intangibles (2025 - 2026)

Veradermics (MANE) posted Amortizatization of Intangibles of $73000.0 for Q1 2026, up 461.54% on a QoQ basis from $13000.0 in Q1 2025, and up 461.54% year-over-year from $13000.0 in Q1 2025.

Veradermics (MANE) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends

Veradermics' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $73000.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Veradermics 2.55 Bn 2.55 Bn - 73,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 73,000.00
Mar 31, 2026 73,000.00
Mar 31, 2025 13,000.00
Mar 31, 2025 13,000.00